Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting

Study Identifier
P15-769
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Dermatology - Hidradenitis Suppurativa (HS)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 99 Years

    Protocol Summary

    This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting. The objectives of this study are to estimate the effectiveness of adalimumab treatment on disease severity, to estimate the impact of adalimumab treatment on patients' quality of life, psychological effect, work productivity and healthcare resource utilization and to describe treatment practices over the study period.

    Study Locations

    Location
    Status
    Location
    Krankenanstalt Rudolfstiftung /ID# 166804
    Vienna, State of Vienna, Austria, 1030
    Status
    Not applicable
    Location
    LKH-Univ. Klinikum Graz /ID# 166802
    Graz, Austria, 8036
    Status
    Not applicable
    Location
    Klinikum Wels - Grieskirchen /ID# 158017
    Wels, Austria, 4600
    Status
    Not applicable
    Location
    UZ Brussel /ID# 154218
    Jette, Brussels Capital, Belgium, 1090
    Status
    Not applicable
    Location
    Cliniques Universitaires Saint Luc /ID# 154217
    Woluwe-Saint-Lambert, Brussels Capital, Belgium, 1200
    Status
    Not applicable
    Location
    CHU de Liege /ID# 154220
    Liège, Liege, Belgium, 4000
    Status
    Not applicable
    Showing {first} - {last} of {total} Results